HKMPF (Hikma Pharmaceuticals) Days Payable : 96.09 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Days Payable?

Hikma Pharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was $407 Mil. Hikma Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was $773 Mil. Hence, Hikma Pharmaceuticals's Days Payable for the six months ended in Dec. 2023 was 96.09.

The historical rank and industry rank for Hikma Pharmaceuticals's Days Payable or its related term are showing as below:

HKMPF' s Days Payable Range Over the Past 10 Years
Min: 54.51 Med: 76.42 Max: 91.62
Current: 91.46

During the past 13 years, Hikma Pharmaceuticals's highest Days Payable was 91.62. The lowest was 54.51. And the median was 76.42.

HKMPF's Days Payable is ranked better than
53.89% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.205 vs HKMPF: 91.46

Hikma Pharmaceuticals's Days Payable increased from Dec. 2022 (73.59) to Dec. 2023 (96.09). It may suggest that Hikma Pharmaceuticals delayed paying its suppliers.

Hikma Pharmaceuticals Days Payable Historical Data

The historical data trend for Hikma Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Days Payable Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

89.54

90.45

78.86

78.91

73.74

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															68.30	78.37	73.59	102.02	96.09

Competitive Comparison of Hikma Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hikma Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's Days Payable falls into.

Hikma Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hikma Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (291	+	309)	/	2 )	/	1485	*	365
=	300					/	1485	*	365
=	73.74

Hikma Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (505	+	309)	/	2 )	/	773	*	365 / 2
=	407					/	773	*	365 / 2
=	96.09

Hikma Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HIKl:UK HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.